Efferocytosis signatures as prognostic markers for revealing immune landscape and predicting immunotherapy response in hepatocellular carcinoma

MLA

Ke Xu, et al. “Efferocytosis Signatures as Prognostic Markers for Revealing Immune Landscape and Predicting Immunotherapy Response in Hepatocellular Carcinoma.” Frontiers in Pharmacology, vol. 14, June 2023. EBSCOhost, https://doi.org/10.3389/fphar.2023.1218244.

APA

Ke Xu, Yu Liu, Huiyan Luo, & Tengfei Wang. (2023). Efferocytosis signatures as prognostic markers for revealing immune landscape and predicting immunotherapy response in hepatocellular carcinoma. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1218244

Chicago

Ke Xu, Yu Liu, Huiyan Luo, and Tengfei Wang. 2023. “Efferocytosis Signatures as Prognostic Markers for Revealing Immune Landscape and Predicting Immunotherapy Response in Hepatocellular Carcinoma.” Frontiers in Pharmacology 14 (June). doi:10.3389/fphar.2023.1218244.